Tagged Articles

attorneys 340 articles

Opening arguments begin in transvaginal mesh injury case

transvaginal mesh

Boston Scientific Corp. manufactured and sold a transvaginal mesh device that was never properly tested for safety and efficacy, and ignored warnings regarding the plastic used to make the implant, the plaintiff attorney told a California jury during opening arguments this week in a product liability lawsuit alleging the company’s transvaginal mesh caused serious injuries. Rosanne Sanchez filed the lawsuit against Boston Scientific in 2012, becoming one of thousands of plaintiffs suing manufacturers of transvaginal mesh implants over claims that the devices were defectively designed and caused injuries. Transvaginal mesh, also known as vaginal mesh, pelvic mesh or bladder sling, ... Read More

Philadelphia court system establishes Xarelto mass tort


Philadelphia’s court system has established a new Xarelto mass tort involving about 170 plaintiffs alleging uncontrollable and sometimes fatal bleeding with the blood thinning drug. The lawsuits name Johnson & Johnson subsidiary Janssen Pharmaceuticals and Bayer Healthcare Pharmaceuticals as the defendants. The city’s first Xarelto side effects lawsuit was filed in the Philadelphia Court of Common Pleas in February 2014 and since then the cases have been mounting. In November 2014, 19 new cases were filed followed by 26 in December, 17 in January 2015, 37 in February and 50 in March. Some attorneys suspect more cases will follow once it is ... Read More

Judge approves NFL concussion compensation package for retired athletes

NFL Logo

A landmark deal between the National Football League (NFL) and former players to compensation for concussion-related injuries has been approved by a federal judge, and could cost the league as much as $1 billion over 65 years, according to projections. The settlement was first announced in August 2013, but capped the compensation at $765 million over 65 years. Concerns were raised that the fund wasn’t enough to cover health care and other benefits for the retired athletes and their survivors. The NFL finally agreed to lift the cap. Total payouts over 65 years, which includes interest and$112 million in attorneys ... Read More

Personal injury lawsuits target testosterone makers


A conference to review the progress of discovery efforts in a group of more than 1,340 lawsuits against manufacturers of testosterone treatments is scheduled for April 21, and the first case is expected to go trial in the fall of 2016. The lawsuits were consolidated in U.S. District Court in the Northern District of Illinois and target seven testosterone makers claiming the drugs caused heart attacks, strokes and other health problems. Testosterone treatments are prescription hormones that are designed to treat hypogonadism, a condition in which men do not produce enough testosterone due to injury or disease. Pharmaceutical companies have ... Read More

Defective metal hips once considered ‘best scientific solution’

metal on metal hip parts

Manufacturers of a metal-on-metal hip replacement system that injured tens of thousands of patients considered the defective metal hips to be “state-of-the-art” and “the best scientific solution available,” until adverse events showed the devices were failing miserably. Johnson & Johnson unit Depuy Orthopaedics introduced the ASR Acetabular hip implant in 2004. The device was considered revolutionary because unlike traditional hip implants, which are made of plastic or ceramic parts, the ASR was designed with all metal parts intended to be more durable and last longer than the 20 years typically given for traditional implants. Within five years, however, the Food and Drug Administration ... Read More

NHTSA to investigate company’s failure to recall Chinese-made tires

shredded tire BA istock

Federal safety regulators are investigating potentially defective Chinese-made tires imported to the U.S. and sold under different brand names by a single distributor after finding that the tires were recalled under one importer but not another. The National Highway Traffic Safety Administration (NHTSA) launched the probe after receiving a tip from a law firm litigating a personal-injury case involving the tires. Lawyers in that case wrote to NHTSA alleging that eight sizes of Hercules Radial A/T tires made for light cars and trucks by Shandong Yongsheng Rubber Co. Ltd. remained on the road when virtually identical tires made by the ... Read More

Ford must submit source code in sudden unintended acceleration case


Ford Motor Co. must turn over portions of its proprietary source code to plaintiffs suing the auto manufacturer over alleged defects in the electronic throttle control (ETC) system of certain vehicles, causing them to accelerate suddenly and unexpectedly, a West Virginia federal judge ordered Friday. Attorneys representing plaintiffs in a proposed class action argued that the source code is instrumental to understanding an alleged glitch that can cause sudden unintended acceleration in vehicles made from 2002 to 2010. They likened the problem to nearly identical claims made against Toyota for sudden unintended acceleration. Electronic source code played a key role ... Read More

Rhode Island man sues Xarelto over bleeding risks


A Rhode Island man is suing the makers of the blood thinner Xarelto claiming the manufacturers misled the public by marketing the drug as safe while not revealing the odds of serious bleeding side effects associated with the drug. The lawsuit also claims that no antidote is available to reverse the blood thinning effects once uncontrolled bleeding occurs. Daniel Hernandez filed his lawsuit against Johnson & Johnson unit Janssen Pharmaceuticals and Bayer Healthcare AG, and several of their subsidiaries that manufacture and distribute Xarelto. The blood thinner, which was initially approved in 2011, is used to prevent strokes in some ... Read More

Takeda dismisses possibility of billion-dollar Actos bladder cancer settlement

Actos (pioglitazone) Type 2 diabetes medication

News that Takeda Pharmaceutical Co. plans to pay $2.2 billion to settle about 8,000 federal and state lawsuits over bladder cancer risks with its type 2 diabetes drug Actos are merely “marketplace rumors,” according to a statement the drug company provided for Law360. “Takeda has confidence in Actos as a treatment option and will continue to vigorously defend the company in these types of cases,” the statement read. “It would be inappropriate to comment further on marketplace rumors.” The statement followed a Bloomberg report that the drug company had offered to pay more than $2.2 billion to resolve Actos bladder ... Read More

FDA releases guidelines for abuse-deterrent versions of opioids


Eighteen months after the Food and Drug Administration (FDA) approved Zogenix Inc.’s powerful opioid painkiller Zyhydro despite abuse concerns from consumer groups and lawmakers, the agency has finalized its guidance urging drug makers to devise abuse-deterrent versions of opioids as they move forward. The new formulations of opioids – some of which have already hit the market – are manufactured in a way that prevents them from being crushed and injected or snorted, which many of these painkillers are for a stronger, more intense high, contributing to the country’s prescription drug abuse epidemic. The FDA guidance informs drug makers of ... Read More